DiaSorin SpA - Company Profile
Powered by
All the data and insights you need on DiaSorin SpA in one report.
$295
- Save hours of research time and resources with
our up-to-date DiaSorin SpA Strategy Report
- Understand DiaSorin SpA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on DiaSorin SpA’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
28 Apr 2021 | DiaSorin Raises USD604 Million in Public Offering of 0% Bonds Due 2028 | Debt Offering | - |
DiaSorin SpA |
11 Apr 2021 | DiaSorin Acquires Luminex | Acquisition |
DiaSorin SpA
|
Luminex Corp |
08 Sep 2020 | DiaSorin Enters into Co-Development Agreement with MeMed | Partnership | - |
MeMed Diagnostics Ltd
DiaSorin SpA |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer